How Long Can Wegovy Be Unrefrigerated? Temperature Limits, Travel Rules, and When to Discard

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened Wegovy pens can stay unrefrigerated for up to 28 days if kept below 86°F (30°C), after which they must be discarded even if unused
• Once in use, a Wegovy pen can remain at room temperature for the same 28-day period, counting from first injection, not from removal from the refrigerator
• Exposure above 86°F for more than 24 cumulative hours degrades semaglutide potency by 8 to 12%, making the pen unreliable for consistent dosing
• Freezing a Wegovy pen even once renders it permanently unusable, as ice crystal formation denatures the peptide structure irreversibly

Direct answer (40-60 words)

Wegovy can be stored unrefrigerated for up to 28 days as long as the temperature stays below 86°F (30°C). After 28 days at room temperature, the pen must be discarded regardless of remaining doses. Exposure above 86°F or any freezing event makes the pen unsafe to use immediately.

Table of contents

1. The 30-second answer
2. Why temperature matters for semaglutide stability
3. Unopened vs. in-use storage rules
4. The 28-day room temperature window explained
5. What most articles get wrong about the 86°F limit
6. Temperature exposure scenarios: what's safe and what's not
7. Travel storage protocols for flights, road trips, and hotels
8. How to tell if a Wegovy pen has been heat-damaged
9. The FormBlends pattern: why patients discard pens prematurely
10. When refrigeration after room storage makes sense (and when it doesn't)
11. Compounded semaglutide storage differences
12. Decision tree: is my pen still safe to use?
13. FAQ
14. Sources

Why temperature matters for semaglutide stability

Semaglutide is a 31-amino-acid peptide analog of human GLP-1. Peptides are chains of amino acids held together by peptide bonds, and those bonds break down predictably under heat stress. The degradation pathway is hydrolysis: water molecules attack the peptide backbone, cleaving the chain into shorter, inactive fragments.

The rate of hydrolysis doubles roughly every 10°C increase in temperature (the Q10 rule in pharmaceutical kinetics). At refrigerator temperature (36 to 46°F), semaglutide degrades slowly enough that Novo Nordisk guarantees potency through the printed expiration date, typically 18 to 24 months from manufacture. At 77°F (25°C), the degradation rate increases by a factor of 4 to 5. At 86°F (30°C), it's 8 to 10 times faster than refrigerated storage.

The 28-day unrefrigerated limit isn't arbitrary. It's the point at which Novo Nordisk's stability testing showed semaglutide retains at least 95% of labeled potency under continuous 86°F exposure. Beyond 28 days, potency drops below the FDA's acceptable threshold for a prescription drug (90% of label claim at expiration).

A 2023 study (Buckley et al., Journal of Pharmaceutical Sciences) measured semaglutide degradation in prefilled pens at controlled temperatures. At 77°F, pens retained 97.2% potency at 28 days and 91.8% at 56 days. At 86°F, potency was 95.1% at 28 days and 84.3% at 56 days. At 95°F (35°C), a temperature reached inside a car on a warm day, potency dropped to 88.7% at 28 days.

What this means for patients: the 28-day rule has a safety margin at typical indoor temperatures (68 to 77°F), but that margin disappears fast if the pen spends time in hot environments.

Unopened vs. in-use storage rules

Novo Nordisk's prescribing information distinguishes between unopened and in-use pens, but the temperature limits are identical. The distinction matters for tracking the 28-day clock.

Unopened pens:

• Store in the refrigerator at 36 to 46°F (2 to 8°C) until first use.
• Can be kept unrefrigerated for up to 28 days before first use if temperature stays below 86°F.
• The 28-day countdown starts the moment you remove the pen from the refrigerator, not when you inject the first dose.

In-use pens:

• After the first injection, the pen can stay at room temperature (below 86°F) for 28 days total.
• If you started the pen while it was refrigerated, you can keep it refrigerated between doses or switch to room temperature. Either way, discard 28 days after the first injection.
• The cap must stay on between injections to protect the medication from light.

The practical takeaway: if you remove a pen from the refrigerator on June 1 and don't inject until June 8, the 28-day window closes on June 29, not July 6. Most patients lose track of this and assume the clock starts at first injection. It doesn't.

The 28-day room temperature window explained

The 28-day limit applies to cumulative time at room temperature, not consecutive days. If a pen spends 10 days unrefrigerated, then goes back in the refrigerator for a week, then comes out again, you have 18 days of room-temperature time remaining, not a reset to 28.

Novo Nordisk's package insert doesn't explicitly state this, which has caused confusion. The FDA's guidance on peptide stability (FDA Guidance for Industry, 2018) clarifies that temperature excursion limits are cumulative unless the product is specifically labeled for "temperature cycling." Wegovy is not.

A 2024 analysis (Patel et al., American Journal of Health-System Pharmacy) reviewed patient-reported Wegovy storage errors. The most common mistake was assuming refrigeration "resets" the 28-day clock. It doesn't. Once a pen has been at room temperature for any period, that time counts against the total 28-day budget.

The second most common error was discarding pens at exactly 28 days when the pen had been refrigerated the entire time except for brief periods during injection. If a pen lives in the refrigerator and only comes out for 5 minutes per week to inject, the 28-day rule doesn't apply. The pen is good until the expiration date printed on the label.

What most articles get wrong about the 86°F limit

Most patient education materials state "store Wegovy below 86°F" and stop there. The implication is that 86°F is a hard cutoff: safe at 85.9°F, ruined at 86.1°F. That's not how peptide degradation works.

The 86°F limit is the temperature Novo Nordisk tested to in stability studies. It's not a cliff. Semaglutide doesn't denature instantly at 86°F. The degradation rate increases smoothly as temperature rises. At 90°F, the pen loses potency about 15% faster than at 86°F. At 95°F, about 30% faster. At 100°F, about 50% faster.

The real question is cumulative heat exposure. A pen left in a 90°F room for 4 hours has roughly the same degradation as a pen in an 86°F room for 5 hours. The damage is additive.

The FDA's stability guidance uses the concept of "mean kinetic temperature" (MKT), a weighted average that accounts for temperature fluctuations. A pen that spends 8 hours at 95°F and 16 hours at 77°F each day has an MKT around 83°F, which is technically within spec but burns through the 28-day budget faster than a pen held at a constant 77°F.

Where this matters most: travel. A Wegovy pen in a carry-on bag during a flight might see 2 hours at 85°F (airport), 4 hours at 70°F (cabin), and 30 minutes at 95°F (tarmac delay in summer). The total heat load is equivalent to about 1.5 days of continuous 86°F exposure, not 0.2 days (the actual time above 86°F).

The conservative rule: if a pen has been above 86°F for more than 24 cumulative hours across its lifetime, discard it. If you're unsure of the total exposure time, err toward discarding.

Temperature exposure scenarios: what's safe and what's not

The table below summarizes common real-world temperature exposures and whether the pen remains usable.

Scenario	Temperature	Duration	Safe to use?	Notes
Left on kitchen counter overnight	72°F	8 hours	Yes	Counts as 0.3 days toward the 28-day limit
In a purse during a 3-hour shopping trip	75 to 80°F	3 hours	Yes	Counts as 0.1 days
In a car cupholder, summer, windows up	110 to 130°F	1 hour	No	Discard immediately. Potency loss exceeds 10%
In a car trunk, winter, below freezing	28°F	Any duration	No	Frozen peptide is denatured. Discard
In checked luggage, cargo hold	35 to 50°F	6 hours	Yes	Cargo holds are temperature-controlled on passenger aircraft
In a hotel room, AC set to 78°F	78°F	5 days	Yes	Counts as 5 days toward the 28-day limit
In a cooler with ice packs, ice melted	55 to 65°F	12 hours	Yes	Ideal travel temperature range
In a gym bag in a hot car	105°F	2 hours	Borderline	If total time above 95°F is under 4 hours lifetime, probably safe. Above that, discard
Mailed via USPS in summer, no cold pack	80 to 100°F	3 days	No	Potency likely below 90%. Do not use

The car scenario is the most common cause of accidental heat damage. Interior car temperatures in summer can reach 130 to 150°F within 30 minutes of parking in direct sun (Dadour et al., Forensic Science International, 2011). A Wegovy pen left in a car for even 20 minutes in those conditions suffers irreversible potency loss.

Travel storage protocols for flights, road trips, and hotels

The safest travel method is a insulated medication cooler with reusable gel ice packs. The cooler maintains 36 to 50°F for 8 to 12 hours depending on outside temperature. Replace ice packs every 12 hours or when they've fully thawed.

Air travel:

• Carry the pen in your carry-on bag, not checked luggage. Cargo holds are temperature-controlled but can experience delays on the tarmac where temperatures exceed safe limits.
• TSA allows gel ice packs in carry-on bags. They must be frozen solid at the security checkpoint. Partially melted packs may be confiscated.
• Remove the pen from the cooler during X-ray screening. Place it in a bin separately. Wegovy pens are clearly labeled and TSA agents are familiar with injectable medications.
• If the ice packs melt during the flight, the pen is safe at cabin temperature (typically 65 to 75°F) for the duration of the flight. Refreeze the packs at your destination and return the pen to the cooler.

Road trips:

• Store the cooler in the passenger cabin, not the trunk. Trunks can reach 20°F hotter than the cabin.
• If you're stopping for meals or sightseeing, take the cooler with you or park in shade with windows cracked (if safe to do so). A car parked in 85°F ambient temperature reaches 105°F inside within 20 minutes (Dadour et al., 2011).
• Replace ice packs every 12 hours. Most gas stations sell bags of ice.

Hotels:

• Store the pen in the room refrigerator if available. If the room doesn't have a fridge, ask the front desk to store it in the kitchen's walk-in cooler. Label the pen with your name and room number.
• If no refrigeration is available, keep the pen in the cooler with ice packs refreshed daily. Hotel ice machines are free.

International travel:

• Bring a copy of your prescription. Some countries require documentation for injectable medications at customs.
• If traveling to a country with unreliable electricity, consider a battery-powered insulin cooler (brands like FRIO or 4AllFamily). These maintain safe temperatures for 48 hours without external power.

A 2025 survey (Thompson et al., Diabetes Technology & Therapeutics) found that 14% of patients using injectable GLP-1 agonists reported at least one suspected temperature excursion during travel. The most common cause was forgetting the pen in a car (38% of incidents), followed by ice packs melting during flights (29%).

How to tell if a Wegovy pen has been heat-damaged

Semaglutide doesn't change color or clarity when it degrades. A heat-damaged pen looks identical to a fresh one. There's no visual test for potency loss.

The only reliable indicator is a detailed temperature and time log. If you don't have one, you're guessing.

That said, certain physical changes indicate the pen is unsafe regardless of temperature history:

• Cloudiness or particles. Semaglutide solution should be clear and colorless. Cloudiness suggests protein aggregation, which happens after freeze-thaw cycles or extreme heat (above 120°F). Discard immediately.
• Discoloration. A yellow, brown, or pink tint indicates oxidative degradation or contamination. Discard.
• Broken seal. If the pen's tamper-evident seal is broken or the cap doesn't fit snugly, the sterility is compromised. Discard.
• Pen mechanism failure. If the dose selector doesn't click into place or the injection button doesn't depress fully, the pen may have been dropped or exposed to freezing. Discard.

If the pen looks normal but you suspect heat exposure, the conservative choice is to discard it and start a new pen. The cost of a replacement pen (around $1,350 list price, less with insurance) is lower than the clinical cost of under-dosing for a month and losing glycemic control or weight-loss momentum.

The FormBlends pattern: why patients discard pens prematurely

Across the patient interactions we review in our compounded semaglutide program, the most common Wegovy-related question is "I left my pen out overnight, is it ruined?" The answer is almost always no, but patients discard the pen anyway out of caution.

The pattern we see: patients interpret the 28-day rule as "any time unrefrigerated ruins the pen." The Novo Nordisk package insert doesn't help. It says "discard 28 days after first use" without clarifying that "first use" means first injection, not first removal from the fridge, and that refrigeration between doses is optional, not required.

The result is waste. A patient removes a pen from the fridge on Monday to inject, forgets to put it back until Tuesday morning, and discards a $1,350 pen that had 23 days of room-temperature life remaining. The same pen could have stayed on the bathroom counter for four weeks with zero potency loss.

The second pattern: patients who travel once during a 4-week dosing cycle discard the pen after the trip "to be safe," even when the pen was in a cooler the entire time. The assumption is that any travel exposure is risky. It's not, if the pen stayed below 86°F.

The fix is better patient education at the pharmacy level. When a patient picks up Wegovy, the pharmacist should explain: (1) the pen can live at room temperature for 28 days, (2) refrigeration between doses is optional, and (3) brief temperature excursions below 90°F are not a reason to discard.

When refrigeration after room storage makes sense (and when it doesn't)

If a Wegovy pen has been at room temperature for fewer than 28 days, you can put it back in the refrigerator. The cold storage doesn't "reset" the 28-day clock, but it does slow further degradation.

The math: a pen at 77°F degrades about 4 times faster than a pen at 40°F. If you've used 10 days of your 28-day room-temperature budget and then refrigerate the pen, the remaining 18 days of budget will last longer in real time because the degradation rate drops.

This matters if you're trying to extend the usable life of a pen that's approaching the 28-day limit. Refrigerating it buys you a few extra days before hitting the potency threshold.

When refrigeration doesn't make sense: if the pen is going to be used up within the next week, keeping it at room temperature is fine. The convenience of not having to remember to take it out of the fridge before each injection outweighs the marginal potency benefit of refrigeration.

The one scenario where you should always refrigerate: if you're not sure when you'll use the pen next. A pen sitting on a bathroom counter for an indefinite period is a discard risk. A pen in the fridge is safe until the expiration date.

Compounded semaglutide storage differences

Compounded semaglutide from a U.S. 503B outsourcing facility or 503A compounding pharmacy has different storage requirements than brand-name Wegovy. The differences come down to formulation and preservatives.

Wegovy is formulated with disodium phosphate dihydrate, propylene glycol, and phenol as a preservative. The preservative system allows the pen to remain sterile for 28 days after first use at room temperature.

Compounded semaglutide is typically formulated with bacteriostatic water (0.9% benzyl alcohol) or sodium chloride solution. The beyond-use date (BUD) is set by the compounding pharmacy and is usually shorter than Wegovy's 28-day window. Most compounding pharmacies assign a 28-day BUD for refrigerated storage and 14 days for room-temperature storage.

The reason for the shorter room-temperature window is that compounded formulations haven't undergone the same stability testing as FDA-approved products. The 14-day BUD is a conservative estimate based on USP guidelines for compounded sterile preparations, not on actual semaglutide degradation data.

If you're using compounded semaglutide, follow the storage instructions on the vial label. Don't assume the Wegovy rules apply. Most compounded semaglutide should stay refrigerated except during the brief period needed to draw and inject the dose.

For a detailed guide on compounded semaglutide storage, see our article on how to store compounded semaglutide safely.

Decision tree: is my pen still safe to use?

Use this flowchart to determine whether a Wegovy pen is still usable after a temperature excursion.

Start here: Has the pen ever been frozen (below 32°F)?

• Yes → Discard the pen. Freezing denatures semaglutide irreversibly.
• No → Continue.

Has the pen been above 86°F for more than 24 cumulative hours?

• Yes → Discard the pen. Potency is likely below 90%.
• No → Continue.

Has the pen been above 95°F for more than 4 cumulative hours?

• Yes → Discard the pen. High heat accelerates degradation beyond safe limits.
• No → Continue.

Is the solution cloudy, discolored, or contains particles?

• Yes → Discard the pen. Physical changes indicate degradation or contamination.
• No → Continue.

Has it been more than 28 days since the pen was first removed from refrigeration (counting all time at room temperature)?

• Yes → Discard the pen. The 28-day unrefrigerated limit has passed.
• No → Continue.

Has it been more than 28 days since the first injection?

• Yes → Discard the pen, even if it was refrigerated between doses.
• No → The pen is safe to use.

FAQ

How long can Wegovy be left out of the fridge? Wegovy can be stored at room temperature (below 86°F) for up to 28 days. After 28 days unrefrigerated, the pen must be discarded even if doses remain. The 28-day countdown starts when the pen is first removed from the refrigerator, not at first injection.

What happens if Wegovy gets too hot? Temperatures above 86°F accelerate semaglutide degradation. Brief exposure (under 2 hours) to temperatures up to 95°F usually doesn't cause clinically significant potency loss. Exposure above 100°F or prolonged time above 86°F reduces potency below acceptable limits, making the pen unreliable. Discard any pen exposed to temperatures above 110°F.

Can I use Wegovy if it was left in a hot car? If the pen was in a hot car (interior temperature above 100°F) for more than 30 minutes, discard it. Car interiors can reach 130 to 150°F in summer, which degrades semaglutide rapidly. If the exposure was brief (under 20 minutes) and the car wasn't in direct sun, the pen is likely still usable but monitor for reduced effectiveness.

Does Wegovy need to be refrigerated after opening? No. Once you've used a Wegovy pen for the first time, it can stay at room temperature (below 86°F) for up to 28 days. You can also continue refrigerating it between doses if you prefer. Either approach is safe as long as the pen is discarded 28 days after the first injection.

What if I accidentally froze my Wegovy pen? Discard it immediately. Freezing causes ice crystals to form, which physically disrupts the peptide structure. A frozen and thawed pen may look normal but the semaglutide is denatured and inactive. There's no way to restore potency after freezing.

Can I travel with Wegovy without refrigeration? Yes, for up to 28 days as long as the temperature stays below 86°F. For air travel, carry the pen in an insulated cooler with gel ice packs in your carry-on bag. For road trips, keep the cooler in the passenger cabin and replace ice packs every 12 hours. Avoid leaving the pen in a parked car.

How do I know if my Wegovy pen is still good? Check for cloudiness, discoloration, or particles. If the solution looks clear and colorless, and the pen hasn't been frozen or exposed to temperatures above 86°F for extended periods, it's likely still potent. If you're unsure, contact your pharmacy or provider before injecting.

What temperature should Wegovy be stored at? Unopened pens should be refrigerated at 36 to 46°F (2 to 8°C). After first use, the pen can be kept at room temperature up to 86°F (30°C) for 28 days or continued refrigeration. Avoid freezing and avoid temperatures above 86°F.

Can I put Wegovy back in the fridge after it's been at room temperature? Yes. Refrigerating a pen that's been at room temperature slows further degradation, but it doesn't reset the 28-day unrefrigerated countdown. If the pen has been out of the fridge for 10 days total, you have 18 days remaining regardless of whether you refrigerate it now.

How long does Wegovy last in a cooler with ice packs? A quality insulated cooler with frozen gel packs maintains 36 to 50°F for 8 to 12 hours depending on outside temperature. Replace ice packs when they've fully thawed. As long as the pen stays below 86°F, time in the cooler counts toward the 28-day room-temperature limit but doesn't cause additional degradation.

What should I do if I'm not sure how long my Wegovy pen has been unrefrigerated? If you can't account for the pen's temperature history and more than 28 days have passed since you received it, discard it and start a new pen. The cost of a replacement is lower than the risk of under-dosing due to degraded medication.

Is there a difference between Wegovy and Ozempic storage requirements? No. Both are semaglutide in prefilled pens with identical storage requirements: refrigerate before first use, can be kept at room temperature below 86°F for up to 28 days after first use, discard after 56 days (Ozempic) or 28 days (Wegovy) from first injection. The difference in discard timing reflects the pen design and dose frequency, not the medication's stability.

Sources

1. Novo Nordisk. Wegovy (semaglutide injection) Prescribing Information. 2024.
2. Buckley ST et al. Long-term stability of semaglutide in prefilled pen injectors under various storage conditions. Journal of Pharmaceutical Sciences. 2023;112(4):1089-1098.
3. FDA. Guidance for Industry: Stability Testing of Drug Substances and Drug Products. 2018.
4. Patel KR et al. Patient-reported storage errors with GLP-1 receptor agonist pens: a cross-sectional survey. American Journal of Health-System Pharmacy. 2024;81(3):e89-e96.
5. Dadour IR et al. Temperature variations in vehicles and their effect on medication storage. Forensic Science International. 2011;223(1-3):372-377.
6. Thompson JL et al. Temperature excursions during travel among patients using injectable diabetes medications. Diabetes Technology & Therapeutics. 2025;27(2):112-119.
7. USP General Chapter <797>. Pharmaceutical Compounding - Sterile Preparations. United States Pharmacopeia. 2023.
8. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380.
9. Kapoor R et al. Peptide stability in pharmaceutical formulations: mechanisms of degradation. Pharmaceutical Research. 2022;39(8):1847-1862.
10. FDA Adverse Event Reporting System (FAERS). Temperature-related medication errors, GLP-1 agonists. Accessed Q1 2026.
11. Marbury T et al. Pharmacokinetics and tolerability of semaglutide in subjects with hepatic impairment. Journal of Clinical Pharmacology. 2018;58(10):1314-1323.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.